- Home
- NEGG vs XBIT Comparison
NEGG vs XBIT Comparison
Compare NEGG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- XBIT
- Stock Information
- Founded
- NEGG 2001
- XBIT 2005
- Country
- NEGG United States
- XBIT United States
- Employees
- NEGG N/A
- XBIT N/A
- Industry
- NEGG Other Specialty Stores
- XBIT Pharmaceuticals and Biotechnology
- Sector
- NEGG Consumer Discretionary
- XBIT Health Care
- Exchange
- NEGG Nasdaq
- XBIT Nasdaq
- Market Cap
- NEGG 122.3M
- XBIT 89.6M
- IPO Year
- NEGG 2010
- XBIT 2015
- Fundamental
- Price
- NEGG $49.24
- XBIT $2.83
- Analyst Decision
- NEGG
- XBIT
- Analyst Count
- NEGG 0
- XBIT 0
- Target Price
- NEGG N/A
- XBIT N/A
- AVG Volume (30 Days)
- NEGG 646.8K
- XBIT 184.6K
- Earning Date
- NEGG 08-28-2025
- XBIT 08-11-2025
- Dividend Yield
- NEGG N/A
- XBIT N/A
- EPS Growth
- NEGG N/A
- XBIT N/A
- EPS
- NEGG N/A
- XBIT N/A
- Revenue
- NEGG $1,235,576,000.00
- XBIT N/A
- Revenue This Year
- NEGG N/A
- XBIT N/A
- Revenue Next Year
- NEGG N/A
- XBIT N/A
- P/E Ratio
- NEGG N/A
- XBIT N/A
- Revenue Growth
- NEGG N/A
- XBIT N/A
- 52 Week Low
- NEGG $3.32
- XBIT $2.50
- 52 Week High
- NEGG $56.00
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- NEGG 91.69
- XBIT 46.44
- Support Level
- NEGG $15.31
- XBIT $2.95
- Resistance Level
- NEGG $17.52
- XBIT $3.32
- Average True Range (ATR)
- NEGG 4.56
- XBIT 0.17
- MACD
- NEGG 2.70
- XBIT 0.01
- Stochastic Oscillator
- NEGG 85.35
- XBIT 40.24
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.